paper
describ
develop
evalu
situ
hybrid
ish
detect
rhinoviru
cell
obtain
nasal
wash
volunt
infect
human
rhinoviru
twentyf
volunt
inocul
evid
infect
viru
isol
ish
respect
least
one
day
investig
viru
challeng
contrast
volunt
signific
antibodi
rise
detect
neutral
test
volunt
inocul
symptom
cold
posit
viru
isol
ish
respect
least
one
day
six
signific
antibodi
rise
neuizat
similarli
volunt
chleng
asymptomat
posit
viru
isol
ish
respect
least
one
day
asymptomat
volunt
show
signific
antibodi
rise
neutral
signific
associ
detect
rhinovirus
ish
viru
isol
third
day
viru
challeng
group
whole
symptomat
group
rest
show
gener
rhinoviru
detect
ish
compar
well
viru
isol
test
clearli
sensit
neutral
test
detect
evid
infect
conclud
ish
interest
new
techniqu
may
play
import
role
studi
rhinoviru
infect
pathogenesi
human
rhinovirus
hrv
major
caus
agent
common
cold
couch
recent
presenc
rhinoviru
nasal
secret
individu
present
symptom
common
cold
could
demonstr
cultiv
asensit
cell
organ
cultur
alnakib
tyrrel
recent
howev
cdna
probe
success
use
detect
presenc
viral
rna
filter
hybrid
assay
although
virus
present
low
concentr
io
tcid
ml
may
detect
alnakib
et
al
situ
hybrid
recent
appli
rapid
diagnosi
number
viru
infect
cytomegaloviru
cmv
liver
graft
cell
naoumov
et
al
herp
simplex
viru
hsv
brain
cell
forghani
et
al
human
papillomaviru
cervic
tissu
burn
et
al
adenovirus
cell
obtain
nasopharyng
secret
gome
et
al
techniqu
use
viral
nucleic
acid
sequenc
locat
within
individu
cell
use
complementari
probe
label
isotop
phosphoru
nonisotop
label
biotin
report
applic
situ
hybrid
detect
rhinovirus
directli
cell
obtain
nasal
wash
human
volunt
infect
rhinoviru
techniqu
may
import
applic
detect
infect
demonstr
viru
rna
singl
cell
also
studi
pathogenesi
viru
respiratori
tract
nasal
wash
sampl
volunt
collect
recent
describ
alnakib
tyrrel
half
volum
nasal
wash
use
isol
rhinovirus
half
process
rhinoviru
detect
ish
mucu
sampl
process
ish
remov
use
percol
densiti
centrifug
step
thu
sampl
mix
percol
pb
ratio
percol
final
concentr
layer
onto
percol
cushion
sampl
spun
min
x
g
bench
centrifug
result
mucu
remain
top
gradient
cell
pellet
cell
resuspend
pb
aliquot
onto
multitest
microscop
slide
flow
previous
coat
polyiiysin
air
dri
cell
fix
freshli
prepar
periodatelysineparafoaldehyd
plp
three
part
buffer
lysin
lysin
nal
hpod
one
part
paraformaldehyd
sodium
period
sampl
fix
min
room
temperatur
wash
four
time
steril
water
dehydr
grade
seri
ethanol
wash
loo
respect
min
slide
air
dri
store
requir
control
slide
prepar
infect
confluent
layer
ohio
hela
cell
grown
lab
tek
plow
laboratori
eight
chamber
glass
slide
approxim
cell
show
cytopath
effect
cpe
slide
wash
three
time
pb
fix
plp
describ
clinic
sampl
slide
store
brought
room
temperatur
wash
twice
pb
incub
hcl
min
follow
triton
pb
wash
three
time
pb
incub
proteinas
k
plgml
min
wash
pb
contain
mgml
glycin
slide
dehydr
ethanol
describ
hybrid
carri
hybrid
mixtur
contain
x
ssc
denhardt
reagent
mm
sodium
phosphat
ph
mgml
denatur
salmon
sperm
dna
formamid
dextran
sulphat
plabel
probe
prepar
primer
extens
use
singlestrand
templat
cdna
nucleotid
extrem
noncod
region
genom
describ
previous
alnakib
et
al
probe
label
high
specif
activ
pdatp
immol
amersham
intern
specif
activ
probe
approxim
x
loh
cpmlpg
radioact
label
strand
separ
templat
heat
denatur
min
immedi
use
twenti
microlitr
probe
hybrid
mixtur
appli
well
slide
includ
control
slide
incub
min
h
humidifi
box
hybrid
slide
wash
three
time
min
x
ssc
room
temperatur
overnight
x
ssc
gentl
agit
slide
rins
twice
air
dri
dip
k
nuclear
emuls
ilford
scientif
dilut
l
prewarm
emuls
allow
dri
slide
left
expos
day
develop
cell
counterstain
giemsa
examin
light
microscopi
volunt
sex
age
year
recruit
hous
isol
group
accord
previous
describ
procedur
bear
reed
volunt
took
part
trial
assess
efficaci
steam
inhal
treatment
cold
induc
human
rhinoviru
detail
trial
recent
describ
approv
trial
given
harrow
district
ethic
committe
briefli
observ
period
h
volunt
challeng
twice
h
apart
tcidsa
instil
ml
viru
inoculum
nostril
symptom
assess
score
previous
describ
bear
reed
tyrrel
et
al
mild
moder
sever
cold
consid
signific
nasal
wash
viru
isol
ish
collect
day
day
viru
challeng
day
volunt
complet
data
paramet
assess
eg
clinic
score
viru
isol
ish
result
day
includ
analysi
cell
nasal
wash
sampl
also
collect
period
time
volunt
challeng
coronaviru
viru
whose
nasal
wash
coronaviru
viru
isol
cell
phillpott
sampl
also
found
contain
coronaviru
rna
recent
describ
hybrid
method
myint
et
al
furthermor
process
rhinoviru
rna
detect
ish
manner
sampl
obtain
rhinoviru
challeng
volunt
henc
use
control
rhinovirus
isol
ohio
hela
cell
describ
previous
alnakib
et
al
similarli
signific
rise
antibodi
titr
sampl
taken
prior
viru
challeng
one
collect
week
later
detect
use
neutral
assay
describ
previous
alnakib
tyrrel
statist
analysi
carri
use
spssx
statist
packag
run
vax
machin
chisquar
fisher
exact
test
use
test
associ
viru
isol
ish
antibodi
rise
optim
assay
condit
initi
establish
use
confluent
monolay
ohio
hela
cell
grown
lab
tek
chamber
glass
slide
infect
variou
differ
fix
camoy
part
absolut
alcohol
part
acet
acid
part
chloroform
plpg
periodatelysineparaformaldehydeglutar
paraformaldehyd
glutar
buffer
lysin
see
plp
sodium
period
initi
evalu
howev
plp
gave
consist
result
particularli
use
sinc
also
maintain
cell
morpholog
eighteen
minut
incub
proteinas
k
produc
best
result
wherea
incub
less
min
min
optim
often
result
fewer
cell
posit
cell
collect
centrifug
nasal
wash
rpm
eppendorf
centrifug
min
result
pellet
resuspend
pb
spot
onto
multitest
slide
sampl
mucu
method
adequ
howev
mucu
present
frequent
pellet
cell
later
transfer
multitest
slide
presenc
mucu
prevent
cell
properli
adher
slide
surfac
henc
lost
follow
subsequ
process
use
percol
gradient
separ
mucu
cell
therefor
greatli
improv
cell
retent
although
still
cell
lost
procedur
number
cell
found
differ
nasal
wash
sampl
vari
consider
cell
howev
major
cell
observ
nasal
wash
mononuclear
number
epitheli
cell
sampl
gener
low
cell
averag
cell
per
slide
epitheli
cell
howev
obtain
use
nasal
scrape
although
suitabl
routin
daili
sampl
carri
studi
fig
la
b
show
typic
rhinoviru
rna
posit
neg
cell
detect
ish
thirtyeight
volunt
complet
data
paramet
assess
therefor
includ
present
analysi
seen
tabl
volunt
inocul
evid
infect
viru
isol
ish
respect
least
one
four
day
investig
volunt
signific
antibodi
rise
detect
neutralis
test
volunt
analys
signific
cold
posit
viru
isol
ish
least
one
day
respect
six
signific
antibodi
rise
tabl
similarli
volunt
challeng
asymptomat
posit
viru
isol
ish
least
one
day
respect
tabl
eight
asymptomat
volunt
show
signific
antibodi
increas
neutral
result
clearli
show
viru
isol
ish
sensit
serolog
provid
evid
infect
fig
show
percentag
volunt
show
posit
test
differ
day
viru
challeng
whole
group
volunt
c
onsid
shown
figur
gener
signific
associ
proport
volunt
excret
viru
posit
rna
ish
except
day
viru
challeng
fig
compar
proport
volunt
excret
viru
posit
viral
rna
ish
differ
day
viruschalleng
group
volunt
develop
symptom
cold
shown
figur
gener
volunt
develop
cold
found
posit
viru
isol
ish
first
four
day
viru
challeng
signific
associ
rna
detect
ish
detect
viru
isol
day
howev
day
viru
challeng
volunt
show
posit
test
ish
compar
viru
isol
fig
compar
result
test
differ
day
viru
challeng
asymptomat
group
volunt
consid
gener
signific
associ
p
proport
volunt
posit
result
two
test
compar
serial
nasal
sampl
obtain
volunt
infect
coronaviru
viru
found
neg
rhinoviru
rna
ish
tihen
process
exactli
manner
volunt
challeng
rhinoviru
studi
show
first
time
rhinoviru
rna
detect
situ
hybrid
directli
cell
obtain
nasal
wash
volunt
challeng
rhinoviru
gener
ish
viru
isol
detect
evid
infect
high
propoion
volunt
although
signific
associ
two
test
could
establish
day
viru
challeng
group
whole
symptomat
group
respect
attempt
made
establish
sensit
specif
ish
relat
viru
isol
sinc
clearli
two
test
measur
two
differ
paramet
may
necessarili
present
sampl
thu
viru
isol
score
posit
result
requir
viabl
viru
present
nasal
wash
sampl
particular
day
infect
furthermor
viru
must
replic
success
sensit
cell
cultur
system
produc
recogniz
cpe
contrast
ish
detect
specif
viral
rna
sequenc
cell
present
nasal
wash
irrespect
whether
viabl
viru
present
inde
gome
et
al
also
found
cell
present
nasopharyng
secret
adenoviru
infect
individu
may
show
adenoviru
dna
antigen
ish
immunofluoresc
respect
although
viru
could
conclus
isol
nevertheless
data
gener
demonstr
viral
rna
may
detect
frequent
viru
isol
sampl
obtain
asymptomat
symptomat
infect
individu
contrast
viabl
viru
frequent
detect
symptomat
volunt
rna
complet
unexpect
sinc
symptomat
individu
infect
gener
tend
sever
result
extens
viru
replic
studi
rather
biotin
use
label
cdna
probe
sinc
earli
evalu
biotin
label
probe
ish
show
probe
may
suffici
sensit
detect
rhinoviru
rna
consist
nasopharyng
cell
unpublish
data
inde
experi
similar
kandolf
et
al
detect
enterovir
genom
ish
myocardi
cell
found
high
sensit
could
achiev
use
radiolabel
clone
cdna
probe
similarli
jiang
et
al
also
show
detect
quantit
hepat
viru
infect
cell
essenti
use
probe
improv
sensit
also
intens
hybrid
ish
procedur
describ
studi
clearli
rapid
requir
h
hybrid
day
optim
intens
signal
develop
emuls
interestingli
jiang
et
al
also
found
detect
hav
rna
optim
one
two
week
requir
obtain
optim
result
one
explan
provid
high
copi
number
progeni
viral
genom
present
rel
earli
cell
difficult
specul
studi
copi
number
rhinoviru
genom
may
present
nasal
cell
follow
infect
vivo
man
specif
cdna
rhinoviru
probe
extens
establish
regard
reaction
nucleic
acid
obtain
virus
human
cell
alnakib
et
al
forsyth
et
al
furthermor
studi
serial
nasal
wash
sampl
obtain
volunt
infect
coronaviru
viru
contain
coronaviru
demonstr
viru
isol
rna
hybrid
consist
neg
rhinoviru
rna
ish
addit
prechalleng
nasal
wash
sampl
volunt
neg
rhinoviru
viru
isol
rhinoviru
rna
ish
gener
howev
cell
prechalleng
sampl
ish
procedur
describ
would
clearli
suitabl
routin
diagnosi
rhinoviru
infect
number
reason
exampl
rapid
requir
present
time
probe
therefor
offer
particular
advantag
viru
isol
detect
viral
rna
nasal
wash
use
synthet
oligonucleotid
probe
bruce
et
al
howev
procedur
may
complement
method
use
studi
rhinoviru
pathogen
inde
whole
process
rhinoviru
infect
nasal
epithelium
mechan
produc
diseas
man
still
entir
clear
sperber
hayden
furthermor
role
viru
develop
lower
respiratori
tract
infect
may
seriou
immunocompromis
patient
krilov
et
al
trigger
episod
bronchiti
asthma
gregg
requir
precis
detail
investig
consid
therefor
ish
play
import
role
studi
diseas
process
caus
rhinovirus
respiratori
tract
consid
modif
present
ish
test
make
procedur
attract
wider
applic
exampl
recent
shown
use
synthet
oligonucleotid
probe
correspond
short
highli
conserv
region
end
rhinoviru
genom
could
detect
rhinovirus
investig
bruce
et
al
inde
probe
also
detect
picornavirus
investig
bruce
et
al
clearli
research
develop
sensit
nonisotop
ish
rhinoviru
enteroviru
rna
detect
inde
provid
import
procedur
studi
rhinoviru
enteroviru
infect
pathogenesi
